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The Shaker-type voltage-gated potassium channel, Kv1.3, is believed to be restricted in distribution to lymphocytes and neurons. In
lymphocytes, this channel has gained intense attention since it has been proven that inhibition of Kv1.3 channels compromise T lymphocyte
activation. To investigate possible expression of Kv1.3 channels in other types of tissue, such as epithelia, binding experiments,
immunoprecipitation studies and immunohistochemical studies were performed. The double-mutated, radiolabeled peptidyl ligand, 125I-
HgTX1-A19Y/Y37F, which selectively binds Kv1.1, Kv1.2, Kv1.3 and Kv1.6 channels, was used to perform binding studies in epithelia
isolated from rabbit kidney and colon. The equilibrium dissociation constant for this ligand was found to be in the sub-picomolar range and the
maximal receptor concentration (in fmol/mg protein) 1.68 for colon and 0.61–0.75 for kidney epithelium. To determine the subtype of Kv1
channels, immunoprecipitation studies with 125I-HgTX1-A19Y/Y37F labeled epithelial membranes were performed with specific antibodies
against Kv1.1, Kv1.2, Kv1.3, Kv1.4 or Kv1.6 subunits. These studies demonstrated that Kv1.3 subunits constituted more than 50% of the
entire Kv1 subunit population. The precise localization of Kv1.3 subunits in epithelia was determined by immunohistochemical studies.D 2003 Elsevier B.V. All rights reserved.Keywords: Potassium channel; Epithelia; Kv1.3 subunit; Radiolabeled hongotoxin-1; Binding studies; Immunoprecipitation; Immunohistochemistry1. Introduction
The Kv family of voltage-gated channels constitutes the
largest family of potassium channels. At least nine different
subfamilies of Kv channels named Kv1 to Kv9 exist, and a
number of the genes within the single subfamilies have been
described (for reviews, see Refs. [1,2]). The Kv subfamilies
are able to form heterotetrameric channel complexes both in
vitro [3–5] and in vivo [6–8]. In addition, a number of
modulatory Kv h-subunits have been identified and taken
together the potential complexity of Kv potassium channels
is enormous [9–12]. The group of Kv1 or Shaker channels
has been subject to the most intense investigation among Kv
channels. These channels have predominantly been found
and characterised in the CNS where they participate in the
control of neuronal excitability and the large number of
different combinations of Kv channel complexes give opti-
mal opportunities for strict control of the firing pattern in0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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which were described as early as 1984 in lymphocytes [14].
The Kv1.3 channels were originally cloned from brain tissue
[9–11,15–17] but shortly after also isolated from lympho-
cytes [18]. The presence of Kv1.3 channels in lymphocytes
has attained intense attention since this channel type is
responsible for setting the membrane potential in these cells.
Inhibition of the Kv1.3 channel can prevent the activation
response of lymphocytes [19–21], although Ca2 +-activated
intermediary conductance K+ channel (IK channels) may
also be important for lymphocyte proliferation [22,23].
In addition to their importance for regulation of the
membrane potential, ion channels play an important role for
transport in epithelia. For example in kidney and colon, the
overall transport of salt and water is dependent on the activity
of several types of K+ channels (see, e.g. Refs. [24,25]). It is
therefore of interest that Kv channels have also been identi-
fied in epithelia [26,27]. However, only sparse information is
available concerning the abundance of Kv channels in
epithelial cells, and in particular little in known concerning
the subtype distribution.
M. Grunnet et al. / Biochimica et Biophysica Acta 1616 (2003) 85–9486In the present study, Kv channels were identified and
quantified in kidney and colon epithelia by use of hongo-
toxin-1 (HgTX1), a peptidyl toxin from the scorpion Cen-
truroides limbatus. An iodinated double-mutated form of this
toxin, 125I-HgTX1-A19Y/Y37F, binds with equally high
affinity to Kv1.1, Kv1.2 and Kv1.3 and also recognize
Kv1.6, although with lower affinity [27]. Epithelial mem-
branes prelabeled with 125I-HgTX1-A19Y/Y37F were sub-
sequently immunoprecipitated with specific antibodies raised
against the different Kv1 channel subunits. This gave not
only the possibility to quantify Kv channels in the epithelial
membranes, but also provided information about the presence
of various Kv1 channel subtypes. Such experiments revealed
that Kv1.3 channel subunits are the most abundant among the
epithelial Kv subtypes, and the localization of channels
containing Kv1.3 subunits in kidney and colon was subse-
quently determined in immunohistochemical experiments.2. Materials and methods
2.1. Tissue preparation
New Zealand white rabbits (approximately 2.5 kg) main-
tained on a standard commercial diet (0.13% Na+ and 0.8%
K+) were killed by cervical dislocation and bled. The distal
colon was immediately dissected, cut into pieces of approx. 3
cm, flushed with 0.9% NaCl to remove fecal contents and
placed on ice. The segments were then opened along their
length, and placed with the luminal side upward on a 150 mm
cooled Petri dish. After cleaning the colon thoroughly with
gauze to remove mucus, the colon mucosa was harvested by
gentle scraping with two glass slides [28]. The colon mucosa
was then placed in liquid nitrogen and stored at  80 jC.
The kidneys were immediately removed and placed on a
150 mm ice-cooled Petri dish and cortex, outer medulla and
inner medulla were separated with a scalpel. For a single
kidney, this resulted in approximately 2.50 g of cortex, 0.90
g of outer medulla and 0.50 g of inner medulla. Kidney tissue
was then placed in liquid nitrogen and stored at  80 jC.
2.2. Vesicle preparation
2.2.1. Colon
Two grams of tissue scrapings were homogenized with 30
ml 250 mM sucrose, 1 mM EGTA, 10 mM MOPS–Tris, pH
7.0 Tris with 10 strokes at 1000 rpm in a glass/teflon
homogenizer (Braun-Melsungen) at 0 jC. 1 mM DTT and
0.2 mM PMSF was added just before homogenization. The
homogenate was subjected to low-speed differential sedi-
mentation 500 g for 10 min at 4 jC in a Sorvall SS 34 rotor.
The supernatant containing soluble proteins and crude mem-
brane fractions was decanted and subjected to a high-speed
centrifugation at 207000 g for 30min at 4 jC in a Beckman
Ti 70.1 rotor. The supernatant was discarded and mucus from
the inner side of the centrifuge glasses was removed beforethe pellet was resuspended in 0.5 ml 20mMTris–HCl pH 7.2
and homogenized in the glass/teflon homogenizer with 10
strokes at 1000 rpm. These membrane preparations (‘‘crude
membranes’’), which contain plasma membranes as well as
intracellular membranes from surface and crypt cells were
stored at  20 jC until further use.
2.2.2. Kidney
Approximately 1 g of kidney cortex, outer medulla or
kidney inner medulla were homogenized with 10 ml 250 mM
sucrose, 50 mM NaCl, 10 mM MOPS, 1 mM EGTA Tris–
HCl pH 7.2 with 5 strokes at 1000 rpm in a glass/teflon
homogenizer (Braun-Melsungen) at 0 jC. The homogenate
was subjected to low-speed centrifugation (Sorvall SS-34)
6300 g 15 min at 4 jC. The supernatant containing
membrane fractions was decanted and saved at 0 jC while
the pellet was resuspended in 10 ml 250 mM sucrose, 50 mM
NaCl, 10 mM MOPS, 1 mM EGTA Tris–HCl pH 7.2. The
resuspended pellet was subjected to another low-speed
centrifugation (Sorvall SS-34) 6300 g 15 min at 4 jC.
The two supernatants were mixed and subjected to a high-
speed centrifugation (Sorvall SS-34) 41700 g 35 min at
4 jC. The supernatant was discarded and the pellet resus-
pended in 20 mM Tris pH 7.2 and homogenized in the glass/
teflon homogenizer (10 strokes) at 0 jC. Membrane prepa-
rations were stored at  20 jC until further use.
2.3. Binding assay
The double-mutated, radiolabeled analog of hongotoxin
named 125I-HgTX1-A19Y/Y37F was used as ligand for
binding to kidney and colon epithelia membranes. Incuba-
tion was carried out in 2–4 ml medium consisting of 2.5–
100 mM KCl, 10 mM NaCl, 20 mM Tris–HCl pH 7.4,
0.1% BSA in polystyrene tubes. Nonspecific binding was
defined in the presence of 1 nM non-labeled HgTX1-A19Y/
Y37F and incubation was carried out at room temperature
for 2–4 h except saturation experiments where incubation
was allowed to proceed for 24 h. All serial toxin dilutions
were performed in 150 mM NaCl, 0.1% BSA, 20 mM Tris–
HCl pH 7.4 and always added directly to the incubation
medium to avoid adsorption phenomena. Digitonin was
allowed to incubate with the membranes for 20 min at room
temperature before the ligand was added. The protein
concentration of the membrane vesicles was 100 Ag/ml for
colon, kidney cortex and outer medulla and 50 Ag/ml for
kidney inner medulla except for initial experiments where
different protein concentrations ranging from 12.5 to 500
Ag/ml were tested. At the end of incubation, the samples
were rapidly filtered through Toyo Advantec GC 50 glass
fiber filters (presoaked for at least 60 min in 0.3% (w/v)
polyethylenimine) on a Milipore 1002530 filter apparatus,
followed by two washes with ice-cold buffer consisting of
150 mM NaCl, 20 mM Tris–HCl pH 7.4 (3 ml per wash). In
each experiment, measurements in duplicate were routinely
performed and the data averaged.
Fig. 1. Binding of 125I-HgTX1-A19Y/Y37F to epithelial membranes.
Different amounts of membranes from colon or kidney were incubated with
6.8 pM 125I-HgTX1-A19Y/Y37F in the absence (total binding) or presence
(unspecific binding) of 10 nM unlabeled HgTX1-A19Y/Y37F. Specific
binding was determined as the difference between total and unspecific
binding. The membrane concentration used in the experiments are given in
Ag/ml on the abscissa. The figure shows the specific binding as the mean of
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Kidney or colon epithelia membranes (10 mg) were incu-
bated with 50–100 pM 125I-HgTX1-A19Y/Y37F for 1–2
determinations in duplicate.Fig. 2. Demasking of 125I-HgTX1-A19Y/Y37F binding by digitonin: 100 Ag/ml of
(C) or kidney inner medulla vesicles (D) were incubated for 20 min at room temper
with constant concentrations of 125I-HgTX1-A19Y/Y37F (4.0 pM) were performed
a function of the digitonin to membrane protein ratio. Data points are mean of dh at room temperature in 10 ml incubation buffer consisting
of 5 mM KCl, 150 mM NaCl, 20 mM Tris–HCl pH 7.4. The
suspension was subjected to high-speed centrifugation at
195000 g 20 min. The supernatant was discarded and
the pellet resuspended in 1 ml ice-cold incubation buffer and
subjected to another high-speed centrifugation at
195000 g 20 min. This washing step was repeated twice
to remove unbound 125I-HgTX1-A19Y/Y37F from the pel-
let. After the last wash, the pellet was resuspended in 5 ml
ice-cold incubation buffer and 100 mg Triton X-100 to a
final Triton concentration of 2%. Membranes were allowed
to solubilize for 30–45 min at 0 jC. Solubilized membranes
were subjected to high-speed centrifugation at 272000
g 20 min. The supernatant containing solubilized mem-
branes were stored at 0 jC and solubilization efficiency
determined.
Immunoprecipitation was carried out in Eppendorf tubes
initially prepared by addition of 75 Al 1:2 diluted Protein A
Sepharose (PAS), 200 Al incubation buffer and various
amounts of Kv1.1, Kv1.2, Kv1.3, Kv1.4 or Kv1.6 antibodies.
The specificity of these antibodies has earlier been proven
[6]. The recognition sequence of the different antibodies
within the primary amino acid sequence of the different Kv1
channels was as follows: Kv1.1 aa 458–475; Kv1.2 aa 461–colon vesicles (A), kidney cortex vesicles (B), kidney outer medulla vesicles
ature with increasing concentrations of digitonin before binding experiments
. Specific binding in percentage of control (no digitonin added) is shown as
eterminations in duplicate.
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and Kv1.6 aa 652–669. These suspensions were allowed to
incubate at least 15 min at 4 jCwith slow rotation before two
washes with 500 Al ice-cold incubation buffer were per-
formed. To save the pellet, suspensions were pulse-spun at
18500 g 30 s between each wash. The washed suspen-
sions were kept at 4 jC until addition of solubilized
membranes.
Antibody binding was performed by adding 250
Al solubilized membranes and 250 Al ice-cold incubation
buffer to the washed PAS/antibody complex. Incubation was
carried out for 4 h at 4 jC with slow rotation. After
incubation, eppendorf tubes were pulse-spun for 30 s before
removal of approximately 400 Al supernatant. Four washes
with 1 ml ice-cold incubation buffer were then performed
before pellets were resuspended in 3 250 Al incubation
buffer and transferred to polystyrene tubes for counting in a
1470 Wizardk gamma counter from Wallac.
2.5. Immunohistochemical studies
2.5.1. Kidney
Wistar male rats were anaesthetised with Midizolam/
Hypnorm (i.p.) and perfusion fixed through the left ventricle.Fig. 3. Quantification of 125I-HgTX1-A19Y/Y37F binding sites. Saturation bindi
were performed to colon membranes (A), kidney cortex membranes (B), kidney
Protein concentration was 100 Ag/ml for colon, kidney cortex and kidney outer med
20 min with 0.50 mg digitonin/mg protein (colon membranes) or 0.25 mg digitonin
125I-HgTX1-A19Y/Y37F. Receptor-ligand binding was allowed to proceed for 24 h
result of measurements in duplicate on pooled membranes from six animals.As fixative was used phosphate buffered saline (PBS) plus
3000 i.e. heparin per liter PBS followed by 0.1 M phosphate
buffer with 4% paraformaldehyde (PFA) for 10 min. The
kidneyswere removed, and post-fixed for an additional 24 h in
0.1 M phosphate buffer plus 4% PFA. Kidney fixed in 4%
PFAwas embedded in paraffin and 5 Am serial sections were
cut and mounted on Super Frost Plus object slides. Sections
were dehydrated in xylene–ethanol series, endogenous per-
oxidase activity was blocked in 1% H2O2 in methanol,
washed three times for 5 min in PBS plus 0.1% Triton X-
100, followed by incubation in PBS plus 1% human serum
albumin (hSA) for 1 h. Primary rabbit Kv1.3 antibody was
diluted 1:1500 in PBS plus 1% hSA and sections were
incubated overnight at 4 jC, then washed three times for 5
min in PBS and incubated in donkey–anti-rabbit (Fab2)
biotinylated antibody 1:200 in PBS plus 1% hSA for 1 h at
room temperature. Washed three times in PBS followed by
incubation with StreptAvidin-Biotin-Complex 1:500 Vector
Elite (Vector, Burlingame, USA) for 1 h, washed three times
in PBS and then incubated with 0.05% di-amino-benzidine
(DAB) in 0.01% H2O2 in PBS + 0.1% Triton X-100 for 10
min and finally washed three times in distilled water. One of
the two sections on each slide was counterstained with
hematoxylin, before mounting in DEPEX.ng experiments with increasing concentrations of 125I-HgTX1-A19Y/Y37F
outer medulla membranes (C) and kidney inner medulla membranes (D).
ulla and 60 Ag/ml for kidney inner medulla. Samples were pre-incubated for
/mg protein (kidney membranes) before addition of the indicated amounts of
before specific binding was determined. Each data point shows the average
t Biophysica Acta 1616 (2003) 85–94 892.5.2. Colon
Wistar male rats were anaesthetised and perfusion-fixed in
4% PFA in PBS as described above. The colon was removed,
post-fixed for 24 h in 4% PFA, embedded in paraffin and 5
Am serial sections were cut. The sections were dehydrated in
tolouen-ethanol series, blocked in blocking buffer (PBS
containing 1% BSA, 0.3% Triton X-100 and 5% swine
serum) and incubated overnight at 4 jC with the anti-Kv1.3
antibody in blocking buffer. After rinses, sections were
incubated with Alexa 568-goat anti-rabbit IgG (1:800) for 2
h at room temperature, rinsed again and mounted with
Prolong Antifade kit before being examined by laser scan-
ning confocal microscopy using the LEICATCS SP2 system.
2.6. Protein determination
The concentration of membrane protein was determined
according to Grunnet et al. [29], using BSA as a standard.
2.7. Analysis of data
The results from saturation binding experiments were
subject to a Michaelis–Menten analysis, where the equilib-
rium dissociation constant (Kd) and the maximal receptor
concentration (Bmax) were determined using the one-site
binding equation Y=BmaxX/(Kd +X) where Y= receptor
concentration and X = radioligand concentration. The corre-
lation coefficient for these plots was >0.94. The data from
M. Grunnet et al. / Biochimica eFig. 4. Scatchard analysis of saturation binding experiments. Data obtained from
analysis after linear transformation. The results are shown for colon membranes (A
kidney inner medulla membranes (D). Calculated maximal receptor concentrations (saturation experiments were transformed into Scatchard plots
and the Bmax and Kd values determined from this linear
regression were not significantly different from the values
determined from the one-site binding equation.
2.7.1. Materials
Antibodies against Kv1 channels and recombinant, dou-
ble-mutated HgTX1-A19Y/Y37F (expressed in E. coli,
purified and iodinated as described earlier [27]) were kind
gifts from Dr. Hans Guenther Knaus; donkey-anti-rabbit
(Fab2) biotinylated antibody was from Jackson Immunor-
esearch Laboratories (Pennsylvania, USA); swine serum
was from DAKO A/S (Denmark); Alexa 568-goat anti-
rabbit IgG and Prolong Antifade kit were from Molecular
Probes (Leiden, The Netherlands); Digitonin was from
Serva (Germany), polystyrene tubes were from InterMed
(Denmark) and all other chemicals were from Sigma.3. Results
3.1. Binding of 125I-HgTX1-A19Y/Y37F to epithelial
membranes
For binding studies the radiolabeled, double-mutated,
hongotoxin analog 125I-HgTX1-A19Y/Y37F was employed.
This labeled peptide, which specifically recognizes Kv1.1,
Kv1.2, Kv1.3 and Kv1.6, shows no difference in affinity asthe non-linear saturation experiments in Fig. 3 were subject to a Scatchard
), kidney cortex membranes (B), kidney outer medulla membranes (C) and
Bmax) and equilibrium dissociation constants (Kd) are summarized in Table 1.
Fig. 5. Kv1 subtype classification by immunoprecipitation. Triton X-100
solubilized colon membranes (A) or kidney membranes (B) pre-labeled
with 125I-HgTX1-A19Y/Y37F were subject to precipitation with increasing
amounts of Kv1.1, Kv1.2 or Kv1.3 antibodies. The amounts immunopre-
cipitated 125I-HgTX1-A19Y/Y37F receptor are shown relative to the
maximal immunoprecipitation by the Kv1.3 antibody as a function of the
amount of added antibody. Numbers in brackets indicate the epitope
sequence for the antibodies. Each data point shows the average result of
measurements in duplicate on pooled membranes from six animals.
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tool for the investigation of Kv1 channel distribution in
brain [27]. Fig. 1 shows an initial experiment, where 125I-
HgTX1-A19Y/Y37F binding to different amounts of par-
tially purified membranes from colon and kidney epithelia
was measured. The figure shows that the specific binding is
dependent on the amount of membranes although the
specific binding as a function of the membrane concentra-
tion in these experiments does not show a linear relation-
ship. Membrane concentrations of 12.5 Ag/ml (colon) and
50 Ag/ml (kidney cortex) are practically below the detec-
tion level and in the case of a membrane concentration of
500 Ag/ml (kidney cortex) the binding assay is most likely
saturated. In all further experiments, membrane concentra-
tions of 60–100 Ag/ml were used as indicated in the figure
legends.
As 125I-HgTX1-A19Y/Y37F recognizes and binds to the
outer vestibule of channels containing Kv1.1, Kv1.2, Kv1.3
and Kv1.6 subunits, binding is only possible if the mem-
brane vesicles are orientated right-side-out. Since membrane
vesicle preparations may consists of a heterogenous popula-
tion of right-side-out, inside-out and leaky vesicles, it may be
necessary to demask the binding sites to obtain reliable
quantification of channels by ligand binding. Digitonin has
been shown to be a suitable detergent for demasking of
epithelial vesicles [30]. In Fig. 2, the vesicles from colon and
kidney were pre-incubated with increasing concentrations of
digitonin, before 125I-HgTX1-A19Y/Y37F binding was mea-
sured with constant ligand and receptor concentrations. As
can be seen, maximal binding to colon- and kidney vesicles
was obtained in the presence of a detergent/receptor ratio
between 0.25 and 0.50 mg digitonin/mg protein. For all
further quantification studies, these digitonin concentrations
were therefore applied to secure full access to all 125I-
HgTX1-A19Y/Y37F binding sites. At detergent concentra-
tions exceeding approximately 1.0 mg digitonin/mg protein,
the specific binding of 125I-HgTX1-A19Y/Y37F was severe-
ly attenuated. This is most likely due to the fact that high
detergent concentrations compromise filter retention.
For a number of peptide toxins, specific binding to
potassium channels is reduced in the presence of high
concentrations of K+, since K+ competes with the toxin forTable 1
Quantification of Kv channels in membranes from kidney and colon
epithelia
Tissue Bmax (fmol/mg protein) Kd (pM)
Colon 1.68F 0.21 0.38F 0.09
Kidney cortex 0.75F 0.26 0.35F 0.06
Kidney outer medulla 0.68F 0.28 0.22F 0.03
Kidney inner medulla 0.61F 0.32 0.18F 0.06
The values for Bmax (maximum receptor concentration) and Kd (equilibrium
dissociation constant) were determined from 15 to 25 independent
experiments (colon, n= 25; kidney cortex, n= 25, kidney outer medulla,
n= 15 and kidney inner medulla, n= 15), where specific binding was
determined in duplicate. The membranes originated from six different
animals. Results are given as meansF S.E.binding to the channel pore. However, to obtain 125I-HgTX1-
A19Y/Y37F binding to Kv1.3 channels, a certain amount of
K+ is necessary, most likely to prevent ‘‘pore-collapse’’ [31].
To optimize binding conditions with respect to the K+
concentration, 125I-HgTX1-A19Y/Y37F binding to colon
and kidney vesicles was performed at constant 125I-HgTX1-
A19Y/Y37F and protein concentrations in the presence of
increasing K+ concentrations. In these experiments, K+
between 2.5 and 10 mM increased specific binding to both
membrane preparation by approx. 40% (data not shown). All
further binding experiments were therefore done in the
presence of 5 mM K+.
3.2. Quantification of Kv1 channels in epithelia
Having optimized assay conditions for 125I-HgTX1-
A19Y/Y37F binding, studies were performed to obtain
information about the absolute number of Kv1 channels in
colon- and kidney epithelia. When membrane vesicles were
incubated with increasing concentrations of 125I-HgTX1-
A19Y/Y37F ranging from approximately 10 times below
Fig. 6. Kv1.3 immunoprecipitation with alternative Kv1.3 antibodies.
Triton X-100 solubilized colon membranes pre-labeled with 125I-HgTX1-
A19Y/Y37F were subject to immunoprecipitation as in Fig. 5 with two
different Kv1.3 antibodies raised against unique epitopes. Numbers in
brackets indicate the epitope sequence for the antibodies. Each data point
shows the results of measurements in duplicate as in Fig. 5.
Fig. 7. Immunohistochemical identification of Kv1.3 channels in colon. Confoca
described in Materials and methods without (A,C) and with (B,D) addition of prim
and surface cells (arrowhead) and crypt cells (arrow) can be identified. Specific sta
the crypts and the staining indicate that Kv1.3 is located in the basolateral memb
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in a concentration-dependent manner (Fig. 3). For all mem-
brane fractions, specific binding was found to be a saturable
function of the 125I-HgTX1-A19Y/Y37F concentration.
Non-linear binding data obtained from 125I-HgTX1-A19Y/
Y37F saturation binding studies were transformed into
Scatchard plots. As can be seen in Fig. 4, the transformations
resulted in straight lines, indicating that 125I-HgTX1-A19Y/
Y37F interacts with a single class of receptor sites in both
kidney and colon membranes. The kinetic parameters for
125I-HgTX1-A19Y/Y37F binding to the epithelial mem-
branes are given in Table 1.
According to earlier studies [27], 125I-HgTX1-A19Y/
Y37F binds to homotetrameric Kv1.1, Kv1.2 and Kv1.3
channels with approximately identical affinity (Kd = 0.1–
0.25 pM) and to Kv1.6 channels with a considerable lower
affinity (Kd = 9.6 pM). The Kd values obtained in the present
studies (0.18–0.38 pM, Table 1), therefore, are consistentl scanning images of paraffin tissue sections of rat distal colon stained as
ary antibodies against Kv1.3. Panel B shows a section of colonic epithelium,
ining is mainly located to the crypt cells. Panel D shows an enlargement of
rane of the crypt cells (arrow).
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channels consisting of Kv1.1, 1.2 or 1.3 subunits.
3.3. Subtype characterization of Kv1 channels present in
epithelia
To determine the relative abundance of the Kv1 channel
subunits in the epithelia, colon or kidney membranes were
initially labeled with 125I-HgTX1-A19Y/Y37F, before
immunoprecipitations were performed with specific anti-
bodies against Kv1.1 (Kv1.1-aa 458–475), Kv1.2 (Kv1.2-
aa 461–480), Kv1.3 (Kv1.3-abI-aa 456–474), Kv1.3
(Kv1.3-abII-aa 485–502). Kv1.4 (Kv1.4-aa 605–623) or
Kv1.6 (Kv1.6-aa 652–669). All precipitation experiments
were carried out with increasing amounts of antibody until a
saturable level of precipitation was achieved (Fig. 5). As can
be seen, it was possible to obtain saturable precipitation
levels for the three antibodies raised against Kv1.1, Kv1.2
and Kv1.3 in both colon- and kidney epithelia vesicles. As
expected, no specific precipitation of 125I-HgTX1-A19Y/
Y37F labeled membranes could be demonstrated with anti-
bodies raised against Kv1.4 or Kv1.6 (data not shown). Fig.
5 shows that the most abundant Kv1 subtype in both colon
and kidney epithelia was Kv1.3. For colon membranes
59.5F 2.8% and for kidney membranes 68.9F 8.9% of
the 125I-HgTX1-A19Y/Y37F receptors immunoprecipitableFig. 8. Immunohistochemical identification of Kv1.3 subunits in kidney. Sections
Panel A shows a section of the renal cortex. The glomerulus, the proximal tubule (P
show staining. Panel B shows a section of the outer medulla. The interstitial cells
the collecting ducts (CT). Panels (C and D). Sections of inner medulla showing DT
of capillaries (CAP) and DT is indicated. Arrows without any notion show the pby all Kv1 antibodies could be chelated with antibodies
against Kv1.3. In contrast, much smaller fractions of labeled
receptor could be precipitated with antibodies against Kv1.2
(30.4% for colon membranes and 17.5% for kidney mem-
branes) and against Kv1.1 (10.8% for colon membranes and
13.7% for kidney membranes). The finding that Kv1.3 seems
to be a predominant Kv channel subunit in epithelia was
somewhat surprising, since Kv1.3 channels have been be-
lieved to be located mainly in lymphocytes and neuronal
tissue. Therefore, the immunoprecipitation experiments were
repeated using another antibody directed against Kv1.3,
namely Kv1.3-abII-aa 485–502. These experiments con-
firmed the results obtained with Kv1.3-abI-aa 456–474
antibody for colon membranes (Fig. 6) as well as for kidney
membranes (data not shown). Taken together, these results
strongly indicate that the Kv1.3 is a predominant subunit
among epithelial Kv1 channels.
3.4. Immunohistochemical localization of Kv1.3 channels in
epithelia
The presence of Kv1.3 subunits in epithelia demonstrated
by the binding and immunoprecipitation studies does not
give information concerning the localization of Kv channels
containing the 1.3 subunit, and it could a priori not be
excluded that the membrane preparations could be contam-of rat kidney were immunostained with specific antibodies against Kv1.3.
T) and the distal tubule (DT) can be identified, and none of these structures
(IC) show profound staining, whereas no staining is detected in the DT and
without Kv1.3-staining and Henle’s loop (H) with Kv1.3-staining. Position
osition of the true thin part of the loop of Henle.
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localization of Kv1.3 subunit-containing channels in epithe-
lia, sections from kidney and colon were stained with the
Kv1.3 antibody (Kv1.3-abI-aa 456–474). In the colon,
staining was exclusively identified in the basolateral mem-
brane of the crypt epithelium, whereas no staining could be
detected either in the apical membranes of these cells or in
the surface epithelium (Fig. 7). In kidney, specific staining
was observed mainly in the interstitial cells of the medulla
(Fig. 8A–D). In addition, some staining was observed in the
loop of Henle, in particular at the transition zone to the distal
tubule (Fig. 8D), whereas the actual thin loop showed only
sparse staining (Fig. 8D, arrows). Staining was not observed
in the glomerulus, pars convuluta of proximal and distal
tubule and collecting ducts (Fig. 8A–C).4. Discussion
In the present paper, we determine the abundance of
certain Shaker-type Kv1 channels in kidney and colon by
means of binding studies using radiolabeled hongotoxin-1
(125I-HgTX1-A19Y/Y37F). This radioligand specifically
binds homotetrameric Kv channels of the Kv1.1, Kv1.2,
Kv1.3 and Kv1.6 types and heterotetrameric Kv channels
consisting of these subtypes [27]. The Bmax values for the
125I-HgTX1-A19Y/Y37F binding showed a density for these
Kv channels 1.68F 0.21 fmol/mg protein in colon and from
0.61F 0.32 to 0.75F 0.26 fmol/mg protein in kidney. In
addition, the Kd values of 0.18–0.32 pM suggested the
presence of Kv1.1, Kv1.2 and Kv1.3 subunits. The immuno-
precipitation studies showed that the Kv1.3 subunit is the
most abundant of the Kvs in these organs; the relative
distributions of Kv1.1:Kv1.2:Kv1.3 subunits are 1:3:6 in
colon and 1:1:5 in kidney. Immunohistochemistry showed
that in kidney, the Kv1.3 subunits are mainly expressed in
medullary interstitial cells and in the distal part of the loop of
Henle, whereas in colon our results indicated that Kv1.3
subunits are expressed exclusively in the basolateral mem-
brane of the crypt cells.
From the total amount of 125I-HgTX1-A19Y/Y37F
receptors and from immunoprecipitation studies, it can be
estimated that the density of Kv1.3. channel subunits in
kidney is in the range of 0.5 fmol/mg protein. This is a
rather low number compared to, e.g. rat brain membranes,
where the overall number of Kv1.3 subunits using the same
methods has been determined to approx. 100 fmol/mg
protein [27]. It could a priori be expected that the number
of Kv channels would be considerably higher in the CNS
considering the massive amount of Kv1 channels needed for
conducting action potentials along neurons, but also in
comparison with other renal channels, the abundance of
the Kv1.3 channels in kidney is low; e.g. we have recently
determined that the abundance of high-conductance Ca2 +-
activated K+ channels (BK channels) in kidney is approx.
10 fmol/mg protein. From the immunohistochemical experi-ments, it can be seen that the reason for the low overall
abundance of Kv1.3 subunits in kidney is that the subunits
are only expressed in rather specific parts of the kidney,
namely the epithelial cells in the distal part of the loop of
Henle and in the medullary interstitial cells, and it must be
expected that the local density in these particular cells is
considerably higher.
In the membranes from colon the abundance of Kv1.3
subunits can be calculated to be approx. 1 fmol/mg protein
from the binding experiments and the immunoprecipitation
experiments. This is also a very sparse distribution in
comparison with other K+ channels in this epithelium, since
we have shown in a similar membrane preparation that the
abundance of BK channels is approx. 40 fmol/mg protein
[32]. In contrast to the kidney, the Kv1.3 subunits in the
colon seem to be expressed exclusively in epithelial cells
and more precisely in the basolateral membrane of the
secretory crypt cells and not in the absorptive surface cells
(cf. Fig. 7).
Functional Kv channels may consist of heterotetrameric
complexes of up to four different subunits. It has been
demonstrated that Kv channels can form heterotetrameric
complexes of subunits within the family of Kv1 channels
but not from more remote families such as Kv2 to Kv9
channels. In the brain, it has been possible to determine the
precise composition and relative abundance of such com-
plexes by additive immunoprecipitation studies [6]. This
approach was also attempted in the present study but
unfortunately the distribution of epithelial Kv1 channels
was too sparse to obtain such information. Even though
such analysis could not be performed, it can be concluded
that heterotetrameric complexes containing Kv1.4 and
Kv1.6 subunits are unlikely to be present in epithelia since
no immunoprecipitation could be demonstrated using spe-
cific antibodies for these channels in experiments with 125I-
HgTX1-A19Y/Y37F labeled membranes. The presence of
homotetrameric Kv1.6 channels can also be ruled out as
very improbable since 125I-HgTX1-A19Y/Y37F recognizes
Kv1.6 channels although with lower affinity than for
Kv1.1, 1.2 and 1.3 channels. In contrast, 125I-HgTX1-
A19Y/Y37F does not recognize Kv1.4 homotetrameric
channels and the presence of such channel complexes
cannot be ruled out based on the binding and immunopre-
cipitation studies performed in this study. Since our data
shows that Kv1.3 is the most abundant of the Kv subtypes
examined, the present study is in agreement with papers
identifying Kv1.3 or Kv1.3-like channels in a renal library
[26] and prostate epithelium [33]. However, the signifi-
cance of the presence of voltage-gated potassium channels
such as, e.g. Kv1.3 in epithelia is rather obscure, since the
basolateral membrane potential of these cells in most cases
under normal physiological conditions is believed to be
negative to  60 mV. Kv1.3 channels are not activated
before depolarization to approximately  45 mV and
would therefore not readily be expected to play a role in
epithelia cells. However, it has been suggested that under
M. Grunnet et al. / Biochimica et Biophysica Acta 1616 (2003) 85–9494certain circumstances, extracellular potassium concentra-
tions in kidney interstitium can be as high as 40 mM,
meaning that the membrane potential will be sufficiently
depolarized to activate Kv1.3 channels [26,34]. Indeed a
model considering a possible function of Kv1.3 channels in
renal epithelial cells has been proposed [26]. However, it
should be kept in mind that the present study shows that in
kidney, Kv1.3 channels are found in the highest concen-
tration in interstitial cells, where a possible function for the
channels remains to be established. Also in the colonic
epithelial cells further studies are clearly needed to estab-
lish a possible function of Kv1.3 channels.
Given the existence of Kv1 channels in epithelia it does,
however, make sense that the subtypes identified, namely
Kv1.1 Kv1.2 and Kv1.3, all belong to the group of relatively
slowly inactivating Kv channels, which could be activated in
epithelial cells, provided the membrane potential exceeds
their threshold for activation, e.g. due to a rise in extracel-
lular K+. This is in contrast to the very fast inactivating Kv
channels, e.g. Kv1.4, for which it would be difficult to assign
a role in non-excitable tissues, such as epithelia.
To date Kv1.3 channels have in particular caused atten-
tion because of their involvement in lymphocyte prolifera-
tion [21] and they have been proposed as a target for
immunosuppressive drugs [20]. However, even though the
amount of Kv1.3 channels in epithelia was found to be
modest, these findings raise the question as to whether
Kv1.3 channels will constitute an appropriate target for
immunosuppressive drugs before detailed investigations of
the role of these channels in other cell types have been
performed.
Acknowledgements
Dr. Gu¨nther Knaus is thanked for donation of the 125I-
HgTX1-A19Y/Y37F, Kv antibodies and valuable discus-
sions. We thank Tove Soland, Birthe Lynderup, and Inge
Kjeldsen for expert technical assistance. This work was
supported by the Novo Nordisk Foundation, Velux Founda-
tion, Fonden til Laegevidenskabens Fremme, and the Danish
Medical Research Council. The Novo Nordisk Research
Foundation is thanked for a scholarship to M. Grunnet. H.
Rasmussen was supported by the Danish Heart Foundation
(grant no. 01-1-2-51-22905A).References
[1] M.J. Christie, Clin. Exp. Pharmacol. Physiol. 22 (1995) 944–951.
[2] W.A. Coetzee, Y. Amarillo, J. Chiu, A. Chow, D. Lau, T. McCor-
mack, H. Moreno, M.S. Nadal, A. Ozaita, D. Pountney, M. Saganich,
V.-S. de Miera, B. Rudy, Ann. N.Y. Acad. Sci. 868 (1999) 233–285.
[3] M.J. Christie, R.A. North, P.B. Osborne, J. Douglass, J.P. Adelman,
Neuron 4 (1990) 405–411.
[4] E.Y. Isacoff, Y.N. Jan, L.Y. Jan, Nature 345 (1990) 530–534.
[5] J.P. Ruppersberg, K.H. Schroter, B. Sakmann, M. Stocker, S. Sewing,
O. Pongs, Nature 345 (1990) 535–537.[6] R.O. Koch, S.G. Wanner, A. Koschak, M. Hanner, C. Schwarzer, G.J.
Kaczorowski, R.S. Slaughter, M.L. Garcia, H.G. Knaus, J. Biol.
Chem. 272 (1997) 27577–27581.
[7] M. Sheng, Y.J. Liao, Y.N. Jan, L.Y. Jan, Nature 365 (1993) 72–75.
[8] H. Wang, D.D. Kunkel, T.M. Martin, P.A. Schwartzkroin, B.L. Tem-
pel, Nature 365 (1993) 75–79.
[9] S.H. Heinemann, J. Rettig, H.R. Graack, O. Pongs, J. Physiol. 493
(1996) 625–633.
[10] K. Nakahira, G. Shi, K.J. Rhodes, J.S. Trimmer, J. Biol. Chem. 271
(1996) 7084–7089.
[11] J. Rettig, S.H. Heinemann, F. Wunder, C. Lorra, D.N. Parcej, J.O.
Dolly, O. Pongs, Nature 369 (1994) 289–294.
[12] O. Pongs, T. Leicher, M. Berger, J. Roeper, R. Bahring, D. Wray,
K.P. Giese, A.J. Silva, J.F. Storm, Ann. N.Y. Acad. Sci. 868 (1999)
344–355.
[13] G. Edwards, A.H. Weston, Diabetes Res. Clin. Pract. 28 (1995)
S57–S66 (Suppl.).
[14] T.E. DeCoursey, K.G. Chandy, S. Gupta, M.D. Cahalan, Nature 307
(1984) 465–468.
[15] K.G. Chandy, C.B. Williams, R.H. Spencer, B.A. Aguilar, S. Ghan-
shani, B.L. Tempel, G.A. Gutman, Science 247 (1990) 973–975.
[16] W. Stuhmer, J.P. Ruppersberg, K.H. Schroter, B. Sakmann,M. Stocker,
K.P. Giese, A. Perschke, A. Baumann, O. Pongs, EMBO J. 8 (1989)
3235–3244.
[17] R. Swanson, J. Marshall, J.S. Smith, J.B. Williams, M.B. Boyle, K.
Folander, C.J. Luneau, J. Antanavage, C. Oliva, S.A. Buhrow, Neuron
4 (1990) 929–939.
[18] B. Attali, G. Romey, E. Honore, A. Schmid-Alliana, M.G. Mattei, F.
Lesage, P. Ricard, J. Barhanin, M. Lazdunski, J. Biol. Chem. 267
(1992) 8650–8657.
[19] M.D. Cahalan, K.G. Chandy, Curr. Opin. Biotechnol. 8 (1997)
749–756.
[20] G.C. Koo, J.T. Blake, A. Talento, M. Nguyen, S. Lin, A. Sirotina, K.
Shah, K. Mulvany, D. Hora Jr., P. Cunningham, D.L. Wunderler, O.B.
McManus, R. Slaughter, R. Bugianesi, J. Felix, M. Garcia, J. Wil-
liamson, G. Kaczorowski, N.H. Sigal, M.S. Springer, W. Feeney, J.
Immunol. 158 (1997) 5120–5128.
[21] G.C. Koo, J.T. Blake, K. Shah, M.J. Staruch, F. Dumont, D.
Wunderler, M. Sanchez, O.B. McManus, A. Sirotina-Meisher, P.
Fischer, R.C. Boltz, M.A. Goetz, R. Baker, J. Bao, F. Kayser,
K.M. Rupprecht, W.H. Parsons, X.C. Tong, I.E. Ita, J. Pivnichny,
S. Vincent, P. Cunningham, D. Hora Jr., W. Feeney, G. Kaczor-
owski, Cell Immunol. 197 (1999) 99–107.
[22] B.S. Jensen, N. Odum, N.K. Jorgensen, P. Christophersen, S.P. Ole-
sen, Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10917–10921.
[23] H. Wulff, M.J. Miller, W. Hansel, S. Grissmer, M.D. Cahalan, K.G.
Chandy, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8151–8156;
G. Giebisch, W. Wang, Acta Physiol. Scand. 170 (2000) 153–173.
[24] K. Kunzelmann, M. Mall, Physiol. Rev. 82 (2002) 245–289.
[25] J.L. Rae, Investig. Ophthalmol. Vis. Sci. 34 (1993) 2608–2612.
[26] X. Yao, A.Y. Chang, E.L. Boulpaep, A.S. Segal, G.V. Desir, J. Clin.
Invest. 97 (1996) 2525–2533.
[27] A. Koschak, R.M. Bugianesi, J. Mitterdorfer, G.J. Kaczorowski, M.L.
Garcia, H.G. Knaus, J. Biol. Chem. 273 (1998) 2639–2644.
[28] H. Wiener, C.H. van Os, J. Membr. Biol. 110 (1989) 163–174.
[29] L. Peterson, Anal. Biochem. 83 (1977) 346–356.
[30] M. Grunnet, H.G. Knaus, C. Solander, D.A. Klaerke, Am. J. Physiol.
277 (1999) G22–G30.
[31] A. Melishchuk, A. Loboda, C.M. Amstrong, Biophys. J. 75 (1998)
1828–1835.
[32] A. Hay-Schmidt, M. Grunnet, S.L. Abrahamse, H.G. Knaus, D.A.
Klaerke, Pflugers Arch. 446 (2003) 61–68.
[33] H. Ouadid-Ahidouch, F. Van Coppenolle, X. Bourhis Le, A. Belhaj,
N. Prevarskaya, FEBS Lett. 459 (1999) 15–21.
[34] R.L. Jamison, J. Work, J.A. Schafer, Am. J. Physiol. 242 (1982)
F297–F312.
